This article is more than 5 years old. Information may no longer be current.

Bioventus, LifeLink to co-develop next generation bone allograft for spine, trauma surgery

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Bioventus announced it has entered into an agreement with LifeLink Tissue Bank to co-develop a next generation bone allograft for spine and trauma surgery, according to a press release.

The tissue bank is a division of LifeLink Foundation Inc., which is headquartered in Tampa, Florida. The terms of the agreement between Bioventus and LifeLink were not disclosed.

“Orthobiologics will continue to evolve to meet the needs of patients, surgeons and payers and Bioventus is pleased to begin work on the next generation of bone graft solutions with LifeLink,” Tony Bihl, CEO of Bioventus, said in the release. “This approach is consistent with our strategy to grow sales of our existing products in the surgical orthobiologics space and expand our offering with new product innovations.”

Reference:

www.bioventusglobal.com